- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: PD 0332334
I alt 1174 resultater
-
Yonsei UniversityAfsluttetSlutstadie nyresygdomKorea, Republikken
-
PfizerAfsluttet
-
Ze-yang Ding, MDGeneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)RekrutteringCholangiocarcinom Ikke-operabeltKina
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Ikke rekrutterer endnuKronisk hepatitis b | Anti-PD-1 antistofKina
-
Fudan UniversityIkke rekrutterer endnuMavekræft | MSI-H | Adjuverende terapi | PD-1 immunterapiKina
-
Cancer Hospital of Guangxi Medical UniversityUkendtHepatocellulært karcinomKina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Ikke rekrutterer endnuPlanocellulært karcinom i hoved og halsKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRekrutteringPerihilært cholangiocarcinomKina
-
Ruijin HospitalIkke rekrutterer endnuLymfom, stor B-celle, diffus | Kemoterapi | TransplantationKina
-
Shanghai Zhongshan HospitalRekrutteringCholangiocarcinom, intrahepatisk | PD-L1 | CTLA4Kina
-
Richard D. CarvajalAfsluttetGastrointestinale stromale tumorerForenede Stater
-
Assistance Publique - Hôpitaux de ParisUkendtMelanom BRAF V600E/K muteret | CDNKN2A Tab DefineretFrankrig
-
Xiangya Hospital of Central South UniversityAktiv, ikke rekrutterende
-
Dragonboat Biopharmaceutical Company LimitedShanghai East HospitalUkendt
-
Blokhin's Russian Cancer Research CenterRekrutteringMelanomDen Russiske Føderation
-
Sun Yat-sen UniversityRekrutteringHepatocellulært karcinomKina
-
Assistance Publique - Hôpitaux de ParisIkke rekrutterer endnuUrothelialt karcinom
-
Xiangya Hospital of Central South UniversityWu Jieping Medical FoundationRekrutteringIkke-småcellet lungekræft Metastatisk | HjernemetastaserKina
-
Second Affiliated Hospital, School of Medicine,...RekrutteringHalspulsåreplak | Plak, aterosklerotisk | Immune Checkpoint-hæmmere | Programmeret celledødsprotein 1-hæmmer | Intimal medial tykkelse af den indre halspulsåreKina
-
The First Hospital of Jilin UniversityIkke rekrutterer endnuMavekræft | MR scanning | Neoadjuverende kemoterapi | Neoadjuverende immunterapi | Tomografi, X-Ray Computed
-
Fujian Cancer HospitalIkke rekrutterer endnu
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.Ukendt
-
Ningbo Cancer HospitalUkendtAvanceret kræft | Solid tumor, voksenKina
-
Chinese PLA General HospitalUkendtKræft i bugspytkirtlenKina
-
PfizerAfsluttet
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetAnatomisk fase IV brystkræft AJCC v8 | Prognostisk fase IV brystkræft AJCC v8 | Metastatisk brystkarcinomForenede Stater
-
The Affiliated Hospital of Qingdao UniversityUkendtNSCLC trin IV | PD-1 | ARID1AKina
-
LigaChem Biosciences, Inc.AntibodyChem Biosciences, Inc.RekrutteringAvancerede solide tumorerForenede Stater, Canada
-
LaNova Medicines LimitedAfsluttetAvanceret solid tumorForenede Stater
-
Christoph AufrichtAfsluttetSlutstadie nyresygdomØstrig
-
Wuhan Union Hospital, ChinaRekrutteringGastroøsofageal Junction Cancer | PD-1 | Neoadjuverende kemoradioterapiKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuIndsamling af kanalkarcinomKina
-
Shanghai Zhongshan HospitalAktiv, ikke rekrutterendeGaldevejskræft | PD-1 antistof | Lenvatinib | GemoxKina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Ikke rekrutterer endnuSmåcellet lungekræft i omfattende stadieKina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaHuashan Hospital; Shanghai Public Health Clinical Center; Anhui Chest Hospital og andre samarbejdspartnereIkke rekrutterer endnuIkke-tuberkuløs mykobakteriel lungesygdomKina
-
Ruijin HospitalRekruttering
-
Ruijin HospitalRekrutteringLymfom, stor B-celle, diffus | Kemoterapi | TransplantationKina
-
Biosuccess Biotech Co., Ltd.AfsluttetMyelodysplastisk syndrom | Akut myelogen leukæmiForenede Stater
-
University of NottinghamAfsluttetInfertilitet | Ældring af æggestokkene | Formindsket ovariereserve (DOR) | Forudsagt Dårlig-respondereDet Forenede Kongerige
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRekrutteringFase 0a Blærekræft AJCC v8 | Fase 0 er blærekræft AJCC v8 | Stadie I blærekræft AJCC v8 | Højrisiko ikke-muskelinvasiv blæreurothelial carcinomForenede Stater
-
GlaxoSmithKlineAfsluttet
-
Shanghai Chest HospitalIkke rekrutterer endnuKemoterapi | Immunterapi | Samtidig kemoradioterapi | Esophageal pladecellekarcinom
-
Henan Cancer HospitalCttqUkendt
-
Johnson & Johnson Healthcare Products Division...Afsluttet
-
Yonsei UniversityAfsluttetPlanlagt nyretransplantationKorea, Republikken
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.Aktiv, ikke rekrutterendeNasopharyngealt karcinomKina
-
LI XIN-XIANGIkke rekrutterer endnuAvanceret endetarmskræft | Distal metastaseKina
-
First Affiliated Hospital of Guangxi Medical UniversityRekruttering
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRekrutteringKolorektal cancer | Neoadjuverende terapi | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)Kina